APA (7th ed.) Citation

Bähr, S., Rue, R. W., Smith, C. J., Evans, J. F., Köster, H., Krymskaya, V. P., & Pleimes, D. (2024). Repurposing nitazoxanide for potential treatment of rare disease Lymphangioleiomyomatosis. Biomolecules, 14(10), . https://doi.org/10.3390/biom14101236

Chicago Style (17th ed.) Citation

Bähr, Stella, Ryan W. Rue, Carly J. Smith, Jillian F. Evans, Hubert Köster, Vera P. Krymskaya, and Dirk Pleimes. "Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis." Biomolecules 14, no. 10 (2024). https://doi.org/10.3390/biom14101236.

MLA (9th ed.) Citation

Bähr, Stella, et al. "Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis." Biomolecules, vol. 14, no. 10, 2024, https://doi.org/10.3390/biom14101236.